183 related articles for article (PubMed ID: 10528118)
1. Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus.
Baik EJ; Kim EJ; Lee SH; Moon C
Brain Res; 1999 Oct; 843(1-2):118-29. PubMed ID: 10528118
[TBL] [Abstract][Full Text] [Related]
2. Differential roles of cyclooxygenase isoforms after kainic acid-induced prostaglandin E(2) production and neurodegeneration in cortical and hippocampal cell cultures.
Kim EJ; Lee JE; Kwon KJ; Lee SH; Moon CH; Baik EJ
Brain Res; 2001 Jul; 908(1):1-9. PubMed ID: 11457426
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture.
Hewett SJ; Uliasz TF; Vidwans AS; Hewett JA
J Pharmacol Exp Ther; 2000 May; 293(2):417-25. PubMed ID: 10773011
[TBL] [Abstract][Full Text] [Related]
4. The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus.
Kunz T; Oliw EH
Eur J Neurosci; 2001 Feb; 13(3):569-75. PubMed ID: 11168565
[TBL] [Abstract][Full Text] [Related]
5. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
6. Excitotoxic neurodegeneration induced by intranasal administration of kainic acid in C57BL/6 mice.
Chen Z; Ljunggren HG; Bogdanovic N; Nennesmo I; Winblad B; Zhu J
Brain Res; 2002 Mar; 931(2):135-45. PubMed ID: 11897099
[TBL] [Abstract][Full Text] [Related]
7. Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach.
Maricic N; Ehrlich K; Gretzer B; Schuligoi R; Respondek M; Peskar BM
Br J Pharmacol; 1999 Dec; 128(8):1659-66. PubMed ID: 10588920
[TBL] [Abstract][Full Text] [Related]
8. Bacterial lipopolysaccharide protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins.
Konturek PC; Brzozowski T; Konturek SJ; Taut A; Kwiecien S; Pajdo R; Sliwowski Z; Hahn EG
Digestion; 1998; 59(4):284-97. PubMed ID: 9693198
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines.
Hara A; Yoshimi N; Niwa M; Ino N; Mori H
Jpn J Cancer Res; 1997 Jun; 88(6):600-4. PubMed ID: 9263538
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression in the hippocampus of genetically epilepsy susceptible El mice was increased after seizure.
Okada K; Yuhi T; Tsuji S; Yamashita U
Brain Res; 2001 Mar; 894(2):332-5. PubMed ID: 11251211
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of cyclooxygenase-2 by NS-398 in endotoxin shock rats in vivo.
Futaki N; Takahashi S; Kitagawa T; Yamakawa Y; Tanaka M; Higuchi S
Inflamm Res; 1997 Dec; 46(12):496-502. PubMed ID: 9459080
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 inhibitor ns-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity.
Araki E; Forster C; Dubinsky JM; Ross ME; Iadecola C
Stroke; 2001 Oct; 32(10):2370-5. PubMed ID: 11588328
[TBL] [Abstract][Full Text] [Related]
13. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
14. Behavioral changes and expression of heat shock protein hsp-70 mRNA, brain-derived neurotrophic factor mRNA, and cyclooxygenase-2 mRNA in rat brain following seizures induced by systemic administration of kainic acid.
Hashimoto K; Watanabe K; Nishimura T; Iyo M; Shirayama Y; Minabe Y
Brain Res; 1998 Sep; 804(2):212-23. PubMed ID: 9757041
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
16. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs.
Hirata T; Ukawa H; Yamakuni H; Kato S; Takeuchi K
Br J Pharmacol; 1997 Oct; 122(3):447-54. PubMed ID: 9351500
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
[TBL] [Abstract][Full Text] [Related]
18. Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease.
Tocco G; Freire-Moar J; Schreiber SS; Sakhi SH; Aisen PS; Pasinetti GM
Exp Neurol; 1997 Apr; 144(2):339-49. PubMed ID: 9168834
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor.
Yamamoto T; Nozaki-Taguchi N
Brain Res; 1996 Nov; 739(1-2):104-10. PubMed ID: 8955930
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological analysis of cyclooxygenase-1 in inflammation.
Smith CJ; Zhang Y; Koboldt CM; Muhammad J; Zweifel BS; Shaffer A; Talley JJ; Masferrer JL; Seibert K; Isakson PC
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13313-8. PubMed ID: 9789085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
